Breast Cancer News and Research

Latest Breast Cancer News and Research

Four most common cancers accounted for over half of the 225,000 new cases of malignant cancer registered in England in 2001

The four most common cancers - breast, lung, colorectal and prostate - accounted for over half of the 225,000 new cases of malignant cancer (excluding non-melanoma skin cancer) registered in England in 2001.

30 Jun 2004

Understanding how some diseases evade our body's defense system may help explain the incomplete control of chronic viral infections by the immune system

For Keith Jerome, M.D, Ph.D., the most intriguing question about cancer is not what causes it but why our bodies fail to defend us from the disease after it strikes.

29 Jun 2004

Prince Charles has called for more research into the benefits of complementary therapies for cancer patients

His Royal Highness was speaking at a conference hosted by five major charities, including The Prince of Wales’s Foundation for Integrated Health of which he is President.

28 Jun 2004

A gene involved in the adhesion of cells is less active in breast tumors with a poor prognosis than those that are less aggressive

Physicians may be able to make early decisions on the best treatment for breast cancer, thanks to research published in Breast Cancer Research today.

28 Jun 2004

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

50,000 people or 10% of the 500,000 people in the U.S with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery for coverage of life saving drugs.

26 Jun 2004

There are 9.8 million cancer survivors in the United States

A cancer survivor is defined as anyone who has been diagnosed with cancer, from the time of diagnosis through the balance of his or her life. The findings are published in the June 25 issue of CDC's Morbidity and Mortality Weekly Report, "Cancer Survivorship - United States, 1971 - 2001."

24 Jun 2004

Only about one in twenty women consistently utilized annual mammography over ten years

Women across age, racial and socioeconomic spectrums underutilize the recommended annual breast cancer screening, effectively reducing the life-saving benefits of annual mammography.

24 Jun 2004

Partial breast radiation procedure may benefit cancer patients

Some women with breast cancer who prefer breast conserving surgery consisting of lumpectomy and radiation may choose a procedure that delivers radiation to the malignant tumor and not to the entire breast

23 Jun 2004

European Commission has approved the use of Herceptin® (trastuzumab) in combination with Taxotere®

The approval is based on study results which showed that for women with HER2-positive breast cancer, the combination of Herceptin and Taxotere significantly improved median life expectancy by more than one-third (31 months with Herceptin plus Taxotere vs. 22 months for Taxotere alone).

23 Jun 2004

Discovery of a gene-expression signature common to distinct types of cancer

Researchers at the University of Michigan, Johns Hopkins and the Institute of Bioinformatics in India have discovered a gene-expression "signature" common to distinct types of cancer

23 Jun 2004

NICE guidance on familial breast cancer

"Breast Cancer Care are extremely pleased that NICE has developed this guidance, as it will improve the standards of care for women at risk of familial breast cancer.

23 Jun 2004

More mammograms key to tackling breast cancer

Mammograms have helped to lower death rates from breast cancer, but a new report by the Institute of Medicine suggest a lot more needs to be done to improve breast cancer screening and save even more lives.

22 Jun 2004

Cognitive decline can occur before chemotherapy treatment

In a series of studies in breast cancer patients, researchers at The University of Texas M. D. Anderson Cancer Center have confirmed the presence of “chemobrain” after chemotherapy treatment – but they also discovered that a significant portion of patients have cognitive declines even before chemotherapy.

21 Jun 2004

Chemobrain side effect in women may be overestimated

A new study says the incidence of "chemobrain," a widely reported side effect in women undergoing treatment for breast cancer, may be overestimated.

21 Jun 2004

Women's health study findings

AllPoints Research today announced the results of a women's health study regarding behavior and perception about sexual and cardiovascular health by women aged 40 and older.

16 Jun 2004

New target to stop breast cancer growth

Two proteins that normally help cells move from place to place and are made in large quantities in breast cancer cells work together to promote the survival and spread of breast cancer, according to a new study by scientists at The University of Texas M. D. Anderson Cancer Center.

15 Jun 2004

Cancer drug gefitinib (Iressa) may be able to restore tamoxifen's anticancer activity

A new study has found a possible mechanism for tamoxifen resistance in breast cancer and provides evidence that another cancer drug--gefitinib (Iressa)--may be able to restore tamoxifen's anticancer activity.

15 Jun 2004

Report shows unacceptably high variations in access to cancer drugs across the UK

Cancer information charity CancerBACUP welcomes today’s report into variations of usage of cancer drugs (postcode prescribing) issued by the Department of Health but says the vital issue of accountability and enforcement has been left unresolved, leaving patients still vulnerable to postcode prescribing.

15 Jun 2004

Investigational drug Abraxane is active and well tolerated in women with metastatic breast cancer

Investigational drug Abraxane™ (albumin nanoparticle paclitaxel), administered weekly without steroid premedication, is active and well tolerated in women with metastatic breast cancer whose disease had progressed while they were treated with paclitaxel (Taxol®) and/or docetaxel (Taxotere®).

15 Jun 2004

Carers' Week helps make the UK's six million carers aware that help is there for them

Feelings of isolation are commonly experienced by carers and Macmillan's Befriending schemes are set up to tackle this. They link carers with volunteers to provide one-to-one friendship and emotional support, information and advice.

15 Jun 2004

Breast Cancer News and Research

Latest Breast Cancer News and Research

Four most common cancers accounted for over half of the 225,000 new cases of malignant cancer registered in England in 2001

Understanding how some diseases evade our body's defense system may help explain the incomplete control of chronic viral infections by the immune system

Prince Charles has called for more research into the benefits of complementary therapies for cancer patients

A gene involved in the adhesion of cells is less active in breast tumors with a poor prognosis than those that are less aggressive

50,000 people in the U.S. with cancer, multiple sclerosis, rheumatoid arthritis or hepatitis C will be eligible for a Medicare drug lottery

There are 9.8 million cancer survivors in the United States

Only about one in twenty women consistently utilized annual mammography over ten years

Partial breast radiation procedure may benefit cancer patients

European Commission has approved the use of Herceptin® (trastuzumab) in combination with Taxotere®

Discovery of a gene-expression signature common to distinct types of cancer

NICE guidance on familial breast cancer

More mammograms key to tackling breast cancer

Cognitive decline can occur before chemotherapy treatment

Chemobrain side effect in women may be overestimated

Women's health study findings

New target to stop breast cancer growth

Cancer drug gefitinib (Iressa) may be able to restore tamoxifen's anticancer activity

Report shows unacceptably high variations in access to cancer drugs across the UK

Investigational drug Abraxane is active and well tolerated in women with metastatic breast cancer

Carers' Week helps make the UK's six million carers aware that help is there for them

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Breast Cancer News and Research

Latest Breast Cancer News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in